PMID: 6397022Oct 1, 1984Paper

Microalbuminuria and nerve conduction velocity in type-I diabetics during conventional therapy and during continuous i.v. insulin infusion

Acta diabetologica latina
B MorellE R Froesch

Abstract

The objective of this study was to follow the development of microalbuminuria and nerve conduction velocity under continuous i.v. insulin therapy over a limited period of 4 months. For this purpose, 8 labile type I diabetics were selected (age 33 +/- 8 years, duration of diabetes 16 +/- 9 years) and treated conventionally with two insulin injections daily over 4 months. Afterwards, the same patients were treated with continuous i.v. insulin infusion and finally again with two injections daily over 4 months each. This procedure allowed each diabetic to serve as his own control. HbA1, microalbuminuria, nerve conduction velocity and relative refractory period of the ulnar nerve were checked at monthly intervals. During the continuous i.v. infusion over 4 months, blood sugar values were significantly lower, glucosuria had disappeared almost completely and the glycosylated hemoglobin had fallen to near normal values. The mean rate of albumin excretion was 16 +/- 5 micrograms/min at rest and 76 +/- 26 micrograms/min during exercise (normal: 3.9 +/- 0.4 and 4.8 +/- 1.2 microgram/min, respectively) and did not change significantly. Nerve conduction velocity in the ulnar nerve rose significantly under i.v. insulin therapy from 47.9 +/- ...Continue Reading

References

Jul 19, 1979·The New England Journal of Medicine·F G SilvaK Reemtsma
May 1, 1981·Electroencephalography and Clinical Neurophysiology·S Faisst, M Meyer
Feb 20, 1981·JAMA : the Journal of the American Medical Association·R M Bergenstal, A R Rubenstein
Aug 26, 1982·The New England Journal of Medicine·R S MecklenburgW J Steenrod
Nov 2, 1963·Lancet·H KEEN, C CHLOUVERAKIS

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.